Wouldn’t that be an exciting plot twist? That the release cadence of the big labs doesn’t actually reflect any meaningful improvements, or bigger models, but it’s a marketing ploy to start ratcheting up prices for good ARR numbers prior to the big IPO where the celebrity executives bail out of the stalling plane.